Document is current
Any future updates will be listed below
-
Authors
Hegazy, Ahmed N. http://orcid.org/0000-0002-2946-8251
Krönke, Jan
Angermair, Stefan
Schwartz, Stefan
Weidinger, Carl
Keller, Ulrich
Treskatsch, Sascha
Siegmund, Britta
Schneider, Thomas
-
Funding
Funding for this research was provided by:
Volkswagen Foundation (90 087-1, 92 087)
Deutsche Forschungsgemeinschaft (TRR241-A05)
Deutsche Forschungsgemeinschaft (INST 335/597-1, INST 335/597-1, TRR241-B01, CRC1340, CRC1449)
Charité - Universitätsmedizin Berlin
- License Information
-
More Information
Article History
Received: 10 February 2022
Accepted: 31 May 2022
First Online: 13 June 2022
Declarations
:
: The study was approved by the ethics committee of Charité-Universtitätsmedizin Berlin (EA4/117/21).
: Written informed consent was obtained from the patient and included the consent to publish clinical information.
: B.S. has served as consultant for Abbvie, Arena, BMS, Boehringer, Celgene, Falk, Galapagos, Janssen, Lilly, Pfizer, Prometheus and Takeda and received speaker’s fees from Abbvie, CED Service GmbH, Falk, Ferring, Janssen, Novartis, Pfizer, Takeda [payments were made to the institution]. A.N.H, J.K., T.S., S.S., S.T., S.A., U.K. declare no conflict of interest.
